Fidelity MSCI Health Care Index ETF (FHLC)
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
Fidelity's lower 0.08% fee and broader 338-stock portfolio contrast sharply with iShares' concentrated pharma play, which delivered 60% returns in one year.
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or Simplify's Actively Managed PINK?
Fidelity MSCI Health Care Index ETF provides low-cost, broad-market exposure with an expense ratio of 0.08%. Simplify Health Care ETF uses active management and a philanthropic model to target capital appreciation, resulting in a higher 0.51% expense ratio.
Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?
Fidelity MSCI Health Care Index ETF carries a significantly lower expense ratio of 0.08% compared to 0.38% for iShares U.S. Healthcare ETF Fidelity MSCI Health Care Index ETF provides broader exposure with 334 holdings, while iShares U.S. Healthcare ETF is more concentrated with 100 positions Both funds exhibit similar risk profiles with five-year maximum drawdowns near 18% and nearly identical beta measurements
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund launched on October 21, 2013.
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?
Fidelity MSCI Health Care Index ETF (FHLC) provides broad sector exposure with significantly lower fees than VanEck Biotech ETF (BBH). BBH focuses on just 25 holdings in the biotech space while FHLC holds more than 300 positions across the entire healthcare industry.
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and higher dosing—effectively extends product lifecycles and drives shareholder value.
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?
iShares Global Healthcare ETF provides exposure to international markets, while Fidelity MSCI Health Care Index ETF focuses exclusively on U.S.-based companies. Fidelity MSCI Health Care Index ETF maintains a significantly lower expense ratio than iShares Global Healthcare ETF.
FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026?
Fidelity MSCI Health Care Index ETF (FHLC) offers a lower expense ratio and higher dividend than the iShares U.S. Healthcare ETF (IYH). IYH maintains a more concentrated portfolio, with 101 holdings compared to FHLC's 338 positions.
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.
Expense ratios, asset size, and portfolio strategy set these two healthcare ETFs apart, yet their risk and dividend profiles tell a different story.
If You Hold This Healthcare ETF, You're Losing Big
The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is up 7%.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Launched on October 21, 2013, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Advisors Capital Management LLC Acquires New Position in Fidelity MSCI Health Care Index ETF $FHLC
Advisors Capital Management LLC bought a new position in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) during the undefined quarter, according to the company in its most recent filing with the SEC. The fund bought 72,324 shares of the company's stock, valued at approximately $5,372,000. Advisors Capital Management LLC owned
Assetmark Inc. Sells 9,971 Shares of Fidelity MSCI Health Care Index ETF $FHLC
Assetmark Inc. lowered its stake in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) by 8.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 105,243 shares of the company's stock after selling 9,971 shares during the period. Assetmark
Fidelity MSCI Health Care Index ETF $FHLC is Altfest L J & Co. Inc.’s 8th Largest Position
Altfest L J and Co. Inc. increased its position in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) by 19.2% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 345,718 shares of the company's stock after purchasing an additional 55,673
Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) Short Interest Up 126.7% in February
Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC - Get Free Report) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 100,535 shares, an increase of 126.7% from the February 12th total of 44,344 shares. Based on an average daily trading volume, of 144,995
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Launched on October 21, 2013, the Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Is Fidelity's Health Care ETF A Good Buy Right Now?
Healthcare investing offers defensive characteristics during market turbulence, yet regulatory uncertainty and political risk can trigger sudden selloffs.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
The Fidelity MSCI Health Care Index ETF (FHLC) was launched on October 21, 2013, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
FHLC: Why Patience Matters More Than Precision
Fidelity MSCI Health Care Index ETF offers long-term growth potential, leveraging demographic tailwinds and biotech innovation, but requires patience through cycles. FHLC's market-cap weighting enables dynamic exposure, reducing biotech risk in downturns and capturing upside in rallies, outperforming pure biotech or pharma over a decade. Currently, FHLC is highly concentrated in pharma, with Eli Lilly and Company at ~13%, which enhances near-term resilience but increases drawdown risk if heavyweights underperform.